Ascentage Pharma Group International (AAPG)
US$ 21.170%
Price Chart
Key Statistics
Market Cap
$ 6.35B
P/E Ratio
0.00
Revenue (TTM)
$ 903.03M
Volume
165.37K
52W High
$ 32.15
52W Low
$ 16.50
Dividend Yield
0.00%
Beta
1.00
Technicals
50-Day MA
17.97
200-Day MA
17.97
52 Week High
32.15
52 Week Low
16.5
About AAPG
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's.
Employees
567
Headquarters
Suzhou, China
CEO
Dr. Dajun Yang M.D., Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg